Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controversial therapies

L B Silver1

  • 1Department of Psychiatry, Georgetown University, School of Medicine, Washington, DC 20007, USA.

Journal of Child Neurology
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Parents of children with disabilities should be wary of unproven treatments. Professionals must educate families about controversial therapies and the lack of clinical evidence for purported cures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Attention-deficit/hyperactivity disorder in adult life.

Child and adolescent psychiatric clinics of North America·2000
Same author

Alternative (nonstimulant) medications in the treatment of attention-deficit/hyperactivity disorder in children.

Pediatric clinics of North America·1999
Same author

Clonidine for stimulant-related sleep problems.

Journal of the American Academy of Child and Adolescent Psychiatry·1994
Same author

The Regular Education Initiative: a déjà vu remembered with sadness and concern.

Journal of learning disabilities·1991
Same author

Nonstandard therapies of learning disabilities.

Seminars in neurology·1991
Same author

Attention deficit-hyperactivity disorder: is it a learning disability or a related disorder?

Journal of learning disabilities·1990
Same journal

Birmingham, 1963.

Journal of child neurology·2026
Same journal

Hyperintensity on Diffusion-Weighted Imaging in a MELAS Patient Does Not Necessarily Mean Cytotoxic Edema.

Journal of child neurology·2026
Same journal

Neuromuscular Symptoms of <i>ORAI1</i>-Related Immunodeficiency.

Journal of child neurology·2026
Same journal

Symptoms of Obsessive-Compulsive Disorder, Attention-Deficit/Hyperactivity Disorder, and Autism Spectrum Disorder in Children and Adolescents Attending a Headache Outpatient Clinic and School-Based Controls.

Journal of child neurology·2026
Same journal

Acute Encephalopathy From Central Nervous System Hemophagocytic Lymphohistiocytosis (CNS HLH) in X-Linked Lymphoproliferative Disease Type 1 (XLP-1).

Journal of child neurology·2026
Same journal

The Cost of Fear for Pediatric Neurologic Care.

Journal of child neurology·2026
See all related articles

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Nutritional Science

Background:

  • Parents of children with disabilities seek effective treatments and may be vulnerable to unproven therapies.
  • Controversial treatments often claim quick solutions or cures for complex neurological conditions.
  • Existing research suggests potential links between brain function, nutrition, and allergic reactions in children with neurological disorders.

Purpose of the Study:

  • To inform healthcare professionals about controversial therapies for children with disabilities.
  • To equip professionals to educate parents regarding the scientific validity of proposed treatments.
  • To address the lack of clinically proven treatments based on the relationship between brain function, nutrition, and allergies.

Main Methods:

Related Experiment Videos

  • Literature review on controversial therapies for pediatric disabilities.
  • Analysis of the relationship between brain function, nutrition, and allergic reactions.
  • Emphasis on critical evaluation of treatment claims and supporting data.
  • Main Results:

    • Currently, no treatments based on brain function-nutrition-allergy relationships have demonstrated clinical success for learning disabilities, attention deficit hyperactivity disorder, or other neurologic disorders.
    • Many proposed treatments lack robust scientific evidence and are not widely accepted by the medical community.
    • Anecdotal evidence, popular books, or media presentations are insufficient to validate a treatment's efficacy.

    Conclusions:

    • Healthcare professionals must actively educate parents about unproven and controversial therapies.
    • Parents should critically assess treatment claims, question the lack of widespread professional adoption, and demand supporting data.
    • Avoiding unproved interventions is crucial to prevent potential harm and ensure children receive evidence-based care.